Roche Holding AG Stock News

Novartis (NVS) enters into an agreement with Roche for the manufacturing of the active pharmaceutical ingredient (API) for Actemra/RoActemra.

Earlier this week, Swiss pharma-giant Roche announced that Regeneron's investigational antibody cocktail - casirivimab and imdevimab - reduced risk of symptomatic Covid-19 infections by 81%. As per th

Basel, 16 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new OCREVUS® (ocrelizumab) analyses supporting its significant benefit on disease progression in early-stage relapsing-remitt

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) today announced new 2-year data from Part 2 of FIREFISH, a Phase 2/3 global study eval

Meridian Bioscience Inc. (NASDAQ:VIVO) edged out GenMark Diagnostics Inc. (NASDAQ:GNMK) as the top gainer in the March GenomeWeb Index with a 25% boost in its share price compared to GenMark's 22.5% i

●  Xolair for self-injection offers healthcare providers and appr opriate patients another administration option for more flexibility in managing their treatment Basel, 13 April 2020 - Roche (SIX:

Investors reacted favorably over the announcement that Saluggia, Italy-based DiaSorin SpA (MIL:DIA) is paying $1.8 billion to purchase Austin, Texas-based Luminex Corp. (NASDAQ:LMNX), a developer of p

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the com

Basel, 12 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today confirmed positive results from the phase III REGN-COV 2069 trial assessing the ability of the investigational antibody cocktail casiriv

Basel, 8 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data for its approved and investigational medicines for the treatment of neurological disorders will be presented at t

A common saying among investors is that you have to spend money to make money. If that's the case, the top R&D spenders in the pharmaceutical industry should have a high potential to be among the lead

Basel, 07 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Elecsys Anti-p53 immunoassay for the in vitro quantitative determination of anti-p53 antibodies. This test i

Oncimmune Holdings PLC (LON:ONC) said it landed two substantial new contracts for an infectious disease panel that helps predict the severity of Coronavirus (COVID-19) along with the potential effec

Oncimmune Holdings PLC (LON:ONC) has landed two substantial new contracts for an infectious disease panel that can help predict the severity of COVID-19 along with the potential effectiveness of vacci

ARK Genomic Revolution Multi-Sector ETF: Poised For Continued Underperformance